Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | OncLive
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | Onc…
May 21, 2020
onclive.com
Positive KEYNOTE-522 Overall Survival Results in TNBC | AJMC
5:55
Positive KEYNOTE-522 Overall Survival Results in TNBC | AJMC
Sep 16, 2024
ajmc.com
KEYNOTE-522: pembrolizumabe em pacientes com câncer de mama triplo negativo inicial - Oncologia Brasil
KEYNOTE-522: pembrolizumabe em pacientes com câncer de mama tri…
Dec 9, 2021
oncologiabrasil.com.br
SABCS 2022 Post Hoc Analysis of Adjuvant RT in the Phase 3 KEYNOTE-522 Study: Neoadjuvant Pembro Chemo vs. Placebo Chemo Followed by Adjuvant Pembro vs. Placebo for Early TNBC
SABCS 2022 Post Hoc Analysis of Adjuvant RT in the Phase 3 KEYN…
Dec 21, 2022
vumedi.com
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute discuss updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage #TNBC. https://www.onclive.com/view/dr-schmid-on-pembrolizumab-plus-chemotherapy-in-high-risk-early-stage-tnbc | OncLive
1:55
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute dis…
55 viewsDec 4, 2024
FacebookOncLive
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNBC | OncLive
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
Free Online Keynote Maker - Design Custom Keynotes | Visme
Free Online Keynote Maker - Design Custom Keynotes | Visme
Aug 22, 2020
visme.co
Keynote
Sep 9, 2016
apple.com
Keynote - Features
Aug 14, 2020
apple.com
Design, Criteria, and Endpoints of KEYNOTE 564 | Targeted Oncolog…
Nov 9, 2022
targetedonc.com
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant P…
Dec 15, 2023
targetedonc.com
Dr Lang on Real-World Outcomes With the KEYNOTE-522 Regimen i…
Feb 11, 2025
onclive.com
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head …
Aug 20, 2020
onclive.com
2:57
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted …
3 months ago
targetedonc.com
KEYNOTE-091 Evaluates Adjuvant Pembrolizumab in Resected Early …
Jul 19, 2022
targetedonc.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
Dr. Reck on the Safety of Pembrolizumab in KEYNOTE-024 i…
Sep 30, 2020
onclive.com
1:37
How to adapt the KEYNOTE-522 without cyclophosphamide
170 views1 month ago
YouTubeClube da Mama
20:27
Chemo for Triple Negative Breast Cancer is Finished!!
173 views2 weeks ago
YouTubeLaura G
Dr. Costa on the Implications of the KEYNOTE-522 Trial in TNBC | Onc…
Feb 15, 2023
onclive.com
27:59
Keynote Basics Tutorial
12.1K viewsSep 20, 2019
YouTubeStuffedBox
1:23
Designing a Clinical Trial
12.7K viewsAug 8, 2013
YouTubeEFPIA
5:49
How to use Keynote
69.4K viewsNov 14, 2017
YouTubeOsi's Tech Tips
39:34
Master Keynote: 15 Essential Tips
26.1K viewsApr 3, 2019
YouTubeEnvato Tuts+
3:01
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer
6.8K viewsJul 2, 2018
YouTubeTargeted Oncology
1:45
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced r…
444 viewsFeb 19, 2019
YouTubeecancer
5:12
How to run Keynote Free on PC Windows Computer
88K viewsMay 3, 2018
YouTubeUX Design Master
1:23
3-Year Update Shows Continued Efficacy of Pembrolizumab for Mel…
171 viewsJun 16, 2020
YouTubeTargeted Oncology
1:49
Keynote Manager Features
17.8K viewsMay 20, 2015
YouTubeRevolution Design Software
See more videos
Static thumbnail place holder